Immunomodulatory drugs in myelodysplastic syndromes. [electronic resource]
Producer: 20060818Description: 805-13 p. digitalISSN:- 1744-7658
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- adverse effects
- Animals
- Apoptosis -- drug effects
- Blood Transfusion
- Cell Lineage
- Cells, Cultured -- drug effects
- Chromosome Deletion
- Chromosomes, Human, Pair 5 -- ultrastructure
- Clinical Trials as Topic
- Cytokines -- physiology
- Drug Evaluation, Preclinical
- Drugs, Investigational -- therapeutic use
- Erythrocyte Transfusion
- Erythropoiesis -- drug effects
- Female
- Hematopoietic Stem Cells -- drug effects
- Humans
- Immunologic Factors -- adverse effects
- Lenalidomide
- Male
- Middle Aged
- Myelodysplastic Syndromes -- drug therapy
- NF-kappa B -- antagonists & inhibitors
- Neutropenia -- chemically induced
- Pilot Projects
- Thalidomide -- adverse effects
- Thrombocytopenia -- chemically induced
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.